A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma
Chia Jui Yen, Tae You Kim, Yin Hsun Feng, Yee Chao, Deng Yn Lin, Baek Yeol Ryoo, Dennis Chin Lun Huang, David Schnell, Julia Hocke, Arsène Bienvenu Loembé, Ann Lii Cheng
Research output: Contribution to journal › Journal Article › peer-review
22Scopus
citations
Fingerprint
Dive into the research topics of 'A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma'. Together they form a unique fingerprint.